| Code | 1403C | ||||||||||
| MA number | 88/0423/16-S | ||||||||||
| Product Form: | kit rad 1x20 µg (liek.inj.skl. I.)+1x(liek.inj.skl. II.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Narodowe Centrum Badań Jądrowych, Poland | ||||||||||
| Therapeutic Class: | 88 - RADIOPHARMACA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 12 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 18.10.2016 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Tektrotyd_október 2016.doc
|
| SPC: |
SPC_Tektrotyd_11.2023.pdf
|
| Safety feature | No |
| Data update: | 09.07.2021 |
